47 Einträge gefunden

1. 19q13 amplification is associated with high grade and stage in pancreatic cancer.

   1. Kuuselo, Riina
   2. Simon, Ronald
   3. Karhu, Ritva
   4. Tennstedt, Pierre
   5. Marx, Andreas
   6. Izbicki, Jakob R.
   7. Yekebas, Emre F.

   2010 - Forschungsinformationssystem des UKE
2. Tissue microarrays.

   1. Dancau, Ana Maria
   2. Simon, Ronald
   3. Mirlacher, Martina
   4. Sauter, Guido

   2010 - Forschungsinformationssystem des UKE
3. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

   1. Choschzick, Matthias
   2. Lassen, Paula
   3. Lebeau, Annette
   4. Marx, Andreas
   5. Terracciano, Luigi
   6. Heilenkötter, Uwe
   7. Jänicke, Fritz

   2010 - Forschungsinformationssystem des UKE
4. Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.

   1. Moreira, José M A
   2. Ohlsson, Gita
   3. Gromov, Pavel
   4. Simon, Ronald
   5. Sauter, Guido
   6. Celis, Julio E
   7. Gromova, Irina

   2010 - Forschungsinformationssystem des UKE
5. HER-2 amplification is highly homogenous in gastric cancer-reply.

   1. Marx, Andreas H
   2. Simon, Ronald
   3. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
6. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

   1. Fleischmann, Achim
   2. Schlomm, Thorsten
   3. Köllermann, Jens
   4. Sekulic, Nikolina
   5. Huland, Hartwig
   6. Mirlacher, Martina
   7. Sauter, Guido

   2009 - Forschungsinformationssystem des UKE
7. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.

   1. Choschzick, Matthias
   2. Lebeau, Annette
   3. Marx, Andreas
   4. Tharun, Lars
   5. Terracciano, Luigi
   6. Heilenkötter, Uwe
   7. Jänicke, Fritz

   2009 - Forschungsinformationssystem des UKE
8. Gene amplification in ductal carcinoma in situ of the breast.

   1. Burkhardt, Lia
   2. Grob, Tobias
   3. Hermann, I
   4. Burandt, Eike Christian
   5. Choschzick, Matthias
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2009 - Forschungsinformationssystem des UKE
9. Oestrogen receptor gene (ESR1) amplification is frequent in endometrial carcinoma and its precursor lesions.

   1. Lebeau, Annette
   2. Grob, Tj
   3. Holst, Frederik
   4. Seyedi-Fazlollahi, N
   5. Moch, H
   6. Terracciano, Luigi
   7. Turzynski, A

   2008 - Forschungsinformationssystem des UKE
10. Expression and prognostic relevance of annexin A3 in prostate cancer.

    1. Köllermann, Jens
    2. Schlomm, Thorsten
    3. Bang, Holger
    4. Schwall, Gerhard P
    5. von Eichel-Streiber, Christoph
    6. Simon, Ronald
    7. Schostak, Martin

    2008 - Forschungsinformationssystem des UKE
11. AMACR expression in colorectal cancer is associated with left-sided tumor localization.

    1. Marx, Andreas
    2. Simon, Philipp
    3. Simon, Ronald
    4. Mirlacher, Martina
    5. Izbicki, Jakob R.
    6. Yekebas, Emre F.
    7. Kaifi, Jussuf

    2008 - Forschungsinformationssystem des UKE
12. Marked gene transcript level alterations occur early during radical prostatectomy.

    1. Schlomm, Thorsten
    2. Näkel, Esther
    3. Lübke, Andreas
    4. Buness, Andreas
    5. Chun, Felix
    6. Steuber, Thomas
    7. Graefen, Markus

    2008 - Forschungsinformationssystem des UKE
13. Estrogen receptor gene amplification occurs rarely in ovarian cancer.

    1. Issa, Rana
    2. Lebeau, Annette
    3. Grob, Tobias
    4. Holst, Frederik
    5. Moch, Holger
    6. Terracciano, Luigi
    7. Choschzick, Matthias

    2008 - Forschungsinformationssystem des UKE
14. The apoptosis linked gene ALG-2 is dysregulated in tumors of various origin and contributes to cancer cell viability.

    1. Cour, La
    2. Jonas, M
    3. Høj, Berit R
    4. Simon, Ronald
    5. Sauter, Guido
    6. Sauter, Guido
    7. Berchtold, Martin W

    2008 - Forschungsinformationssystem des UKE - frei zugänglich
15. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

    1. Fleischmann, Achim
    2. Schlomm, Thorsten
    3. Huland, Hartwig
    4. Köllermann, Jens
    5. Simon, Philipp
    6. Mirlacher, Martina
    7. Salomon, Georg

    2008 - Forschungsinformationssystem des UKE
16. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

    1. Dahl, E
    2. Wiesmann, F
    3. Woenckhaus, M
    4. Stoehr, R
    5. Wild, P J
    6. Veeck, J
    7. Knüchel, R

    2007 - Forschungsinformationssystem des UKE
17. Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.

    1. Al-Kuraya, Khawla S
    2. Bavi, Prashant P
    3. Ezzat, Adnan A
    4. Al-Dayel, Fouad A
    5. Uddin, Shahab
    6. Atizado, Valerie L
    7. Al-Jomah, Naif A

    2006 - Forschungsinformationssystem des UKE
18. Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.

    1. Law, Che-Leung
    2. Gordon, Kristine A
    3. Toki, Brian E
    4. Yamane, Andrew K
    5. Hering, Michelle A
    6. Cerveny, Charles G
    7. Petroziello, Joseph M

    2006 - Forschungsinformationssystem des UKE
19. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

    1. Went, P
    2. Vasei, M
    3. Bubendorf, L
    4. Terracciano, L
    5. Tornillo, L
    6. Riede, U
    7. Kononen, J

    2006 - Forschungsinformationssystem des UKE
20. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.

    1. Oeggerli, M
    2. Schraml, P
    3. Ruiz, C
    4. Bloch, M
    5. Novotny, H
    6. Mirlacher, M
    7. Sauter, Guido

    2006 - Forschungsinformationssystem des UKE